CDH1 and breast lobular carcinoma: As reported before (Ciriello et al, 2015), disruptive alterations in CDH1 were a hallmark of lobular carcinomas (135/386 [35.0%] of samples), while alterations in TP53, MAP3K1, and GATA3 were more common in the ductal type.